STOCK TITAN

NEOG insider sale and RSU vesting: 3,534 sold, 9,036 vested

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

NEOGEN CORP (NEOG) reporting person Amy M. Rocklin had 9,036 restricted stock units vest on 10/07/2025, which were settled for an equal number of shares at a recorded per-share amount of $5.63. The filing also shows a disposition of 3,534 shares on 10/07/2025 at $5.63, leaving the reporting person with 49,672 shares beneficially owned following the transactions. The transactions were signed by an attorney-in-fact on 10/09/2025.

Positive

  • 9,036 RSUs vested and were settled into shares on 10/07/2025
  • Reporting person retains 49,672 shares after the transactions, indicating continued ownership

Negative

  • 3,534 shares were disposed on 10/07/2025 at $5.63, reducing holdings from the pre-disposition total

Insights

RSU vesting increased insider ownership while a partial disposition reduced daily holdings.

The reporting person received $5.63-priced restricted stock units that vested and converted into 9,036 shares on 10/07/2025, which directly raised share holdings to 53,206 before a subsequent disposition. A separate line shows a disposition of 3,534 shares at $5.63 on the same date, leaving 49,672 shares after both actions.

These are routine compensation-related events: vesting of RSUs and a contemporaneous sale. Watch short-term changes in insider holdings around vesting dates for future dilution or selling patterns; the vesting and sale occurred on 10/07/2025.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rocklin Amy M

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/07/2025 M 9,036 A $5.36 53,206 D
Common Stock 10/07/2025 F 3,534 D $5.63 49,672 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $5.63 10/07/2025 M 9,036 10/07/2025 10/07/2025 Common Stock 9,036 $5.63 0 D
Explanation of Responses:
Remarks:
Each RSU is the economic equivalent of one share of common stock. On October 7, 2025, these RSUs vested and were settled for an equal number of shares of common stock.
Christopher Sefcheck (Attorney in Fact) 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did NEOG (NEOG) disclose on this Form 4?

Amy M. Rocklin reported 9,036 RSUs vested and settled into shares and a disposition of 3,534 shares, both on 10/07/2025.

How many shares does the reporting person own after the transactions?

The filing shows 49,672 shares beneficially owned following the reported transactions.

What prices are shown for the transactions in the Form 4?

The settled RSUs and the disposition are both recorded with a per-share amount of $5.63 (one non-derivative acquisition line shows $5.36 for a separate code entry).

When did the RSUs vest and when was the Form 4 signed?

The RSUs vested and were settled on 10/07/2025, and the form was signed by an attorney-in-fact on 10/09/2025.

Were these transactions reported as individual or joint filings?

The form is filed by one reporting person (indicated by the checked single-person filing box).
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.55B
215.36M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING